Such findings were paralleled by an inhibition of tumour recurrence after hepatic ischaemia-reperfusion (IR) injury achieved through a knockout of CXCL-10 and Treg-depletion (Figure 1) [22]. This evidence concerns the gene CXCL10 and neoplasm.